Tetracycline impregnation delays collagen membrane degradation in vivo

Journal of Periodontology

Volumn 75, Issue 8, 2004, Pages 1096-1101

  Zohar, Ron ^a   Nemcovsky, Carlos E ^b   Kebudi, Edmon ^b   Artzi, Zvi ^b   Tal, Haim ^b   Moses, Ofer ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Collagen; Membrane, barrier; Membrane, bioabsorbable; Tetracyclines therapeutic use

Indexed keywords

BIOTIN; COLLAGEN; HORSERADISH PEROXIDASE; TETRACYCLINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; BONE REGENERATION; CALVARIA; COLLAGEN DEGRADATION; COMPUTER PROGRAM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; DRUG SOLUTION; FEMALE; HISTOLOGY; IMAGE ANALYSIS; IMPLANT; IN VIVO STUDY; MATERIAL COATING; MEASUREMENT; NONHUMAN; RAT; STAINING; STATISTICAL SIGNIFICANCE; TIME; TISSUE SECTION; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; BIODEGRADATION, ENVIRONMENTAL; COLLAGEN; FEMALE; MEMBRANES, ARTIFICIAL; RATS; RATS, WISTAR; SKULL; STATISTICS, NONPARAMETRIC; TETRACYCLINE;

EID: 4644313959     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.8.1096     Document Type: Article

References (40)

1. Nyman S, Gottlow J, Lindhe J, et al. New attachment formation by guided tissue regeneration. J Periodontal Res 1987;22:252-254.
2. Melcher AH. On the repair potential of periodontal tissues. J Periodontol 1976;47:256-260.
3. Cook SD, Salkeld SL, Rueger DC. Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites. J Oral Implantol 1995;21:281-289.
4. Tal H, Pitaru S, Moses O. Kozlovsky A. Collagen gel and membrane in guided tissue regeneration in periodontal fenestration defects in dogs. J Clin Periodontol 1996;23:1-6.
5. Patino MG, Neiders ME, Andreana S, Noble B, Cohen RE. Collagen as an implantable material in medicine and dentistry. J Oral Implantol 2002;28:220-225.
6. Ziccardi VB, Buchbinder D. Guided tissue regeneration in dentistry. NY State Dent J 1996;62:48-51.
7. Greenstein G, Caton JG. Biodegradable barriers and guided tissue regeneration. Periodontol 2000 1993;1:36-45.
8. Hutmacher D, Hurzeler MB, Schliephake H. A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications. Int J Oral Maxillofac Implants 1996;11:667-678.
9. Garrett S, Loos B, Chamberlain D, Egelberg J. Treatment of intraosseous periodontal defects with a combined adjunctive therapy of citric acid conditioning, bone grafting, and placement of collagenous membranes. J Clin Periodontol 1988;15:383-389.
10. Magnusson I, Batich C, Collins BR. New attachment formation following controlled tissue regeneration using biodegradable membranes. J Periodontol 1988;59:1-6.
11. Warrer K, Karring T, Nyman S, Gogolewski S. Guided tissue regeneration using biodegradable membranes of polylactic acid or polyurethane. J Clin Periodontol 1992; 19:633-640.
12. Brunel G, Piantoni P, Elharar F, et al. Regeneration of rat calvarial defects using a bioabsorbable membrane technique: Influence of collagen cross-linking. J Periodontol 1996;67:1342-1348.
13. Matsumoto T, Okazaki M, Inoue M, et al. Biodegradation of carbonate apatite/collagen composite membrane and its controlled release of carbonate apatite. J Biomed Mater Res 2002;60:651-656.
14. Pfeifer J, Van Swol RL, Ellinger R. Epithelial exclusion and tissue regeneration using a collagen membrane barrier in chronic periodontal defects: A histologic study. Int J Periodontics Restorative Dent 1989;9:262-273.
15. Caffesse RG, Nasjleti CE, Morrison EC, et al. Guided tissue regeneration: Comparison of bioabsorbable and non-bioabsorbable membranes. Histologic and histometric study in dogs. J Periodontol 1994;65:583-591.
16. Gottlow, J, Nyman S. Barrier membranes in the treatment of periodontal defects. Curr Opin Periodontol 1996;3: 140-148.
17. Minabe M, Kodama T, Kogou T, et al. Different cross-linked types of collagen implanted in rat palatal gingiva. J Periodontol 1989;60:35-43.
18. Goissis G, Marcantonio E Jr, Marcantonio RA, et al. Biocompatibility studies of anionic collagen membranes with different degree of glutaraldehyde cross-linking. Biomaterials 1999;20:27-34.
19. Bunyaratavej P. Wang HL. Collagen membranes: A review. J Periodontol 2001;f72:215-229.
20. Minabe M, Kodama T, Hori T, et al. Effects of atelocollagen on the wound healing reaction following palatal gingivectomy in rats. J Periodontal Res 1989;24:178-185.
21. Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994;8:312-319.
22. Armstrong DG, Jude EB. The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc 2002;92:12-18.
23. Korostoff JM, Wang JF, Sarment DL. Analysis of in situ protease activity in chronic adult periodontitis patients: Expression of activated MMP-2 and a 40 KD Serine protease. J Periodontol 2000;71:353-360.
24. Froum SJ, Gomez C, Breault MR. Current concepts of periodontal regeneration. A review of the literature. NY State Dent J 2002;68:14-22.
25. Golub LM, Lee HM, Ryan ME, et al. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998;12:12-26.
26. Greenwald RA, Golub LM, Ramamurthy NS, et al. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: Relationship to bone and cartilage degradation. Bone 1998;22:33-38.
27. Chung CP, Kim DK, Park YJ, et al. Biological effects of drug-loaded biodegradable membranes for guided bone regeneration. J Periodontal Res 1997;32:172-175.
28. Masters LB, Mellonig JT, Brunsvold MA, et al. A clinical evaluation of demineralized freeze-dried bone allograft in combination with tetracycline in the treatment of periodontal osseous defects. J Periodontol 1996;67:770-781.
29. Zarkesh N, Nowzari H, Morrison JL, et al. Tetracyclinecoated polytetrafluoroethylene barrier membranes in the treatment of intraosseous periodontal lesions. J Periodontol 1999;70:1008-1016.
30. Golub LM, McNamara TR, D'Angelo G. A nonantimicrobial chemically modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987;66:1310-1314.
31. Ramamurthy NS, McClain SA, Pirila E, et al. Wound healing in aged normal and ovariectomized rats: Effects of chemically modified doxycycline (CMT-8) on MMP expression and collagen synthesis. Ann NY Acad Sci 1999;878:720-723.
32. Sasaki T, Ramamurthy NS, Golub LM. Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: A quantitative autoradiographic study. Calcif Tissue Int 1992;50:411-419.
33. Bain S, Ramamurthy NS, Impeduglia T, et al. Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone 1997;21:147-153.
34. Bettany JT, Peet NM, Wolowacz RG, et al. Tetracyclines induce apoptosis in osteoclasts. Bone 2000;27:75-80.
35. Kirkwood KL, Golub LM, Bradford PG. Non-antimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts. Ann NY Acad Sci 1999;878:667-670.
36. Kirkwood K, Martin T, Andreadis ST, et al. Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability. Biochem Pharmacol 2003;66:1809-1819.
37. Moses O, Nemcovsky CE, Tal H, Zohar R. Tetracycline modulates collagen membrane degradation in vitro. J Periodontol 2001;72:1588-1593.
38. Turnbull RS, Freeman E. Use of wounds in the parietal bone of the rat for evaluating bone marrow for grafting into periodontal defects. J Periodontat Res 1974;9: 39-43.
39. Duivenvoorden WC, Hirte HW, Singh G. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells. Invasion Metastasis 1997;17:312-322.
40. Karna E, Palka J, Wolczynski S. Doxycycline-induced inhibition of prolidase activity in human skin fibroblasts and its involvement in impaired collagen biosynthesis. Eur J Pharmacol 2001;430:25-31.